HAE‐C1‐INH is caused by either quantitative deficiencies or dysfunctional production of C1‐INH, leading to uncontrolled plasma kallikrein activity, excessive release of bradykinin, and consequent angioedema.3, 4. The gene discussed is KLK4; the disease is hereditary angioedema.